Volume 24 Number 20
31 October 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 20, 31 October

Zhang J, Siller-Farfán JA.
Current and future perspectives of chimeric antigen receptors against glioblastoma.
Immunother Adv. 2022 Jun 1, 2022;2(1):ltac014. doi: 10.1093/immadv/ltac014. PMID: 36284838. Review.

Khalil M, Shah Z, Saeed Baqai MW, Shamim MS.
Intraoperative Seizures During Awake Craniotomy for Brain Tumours.
J Pak Med Assoc. 2022 Sep;72(9):1878-1879. doi: 10.47391/JPMA.22-95? PMID: 36281000. Review.

Li Y, Qin Q, Zhang Y, Cao Y.
Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis.
Curr Oncol. 2022 Sep 23, 2022;29(10):6893-6907. doi: 10.3390/curroncol29100542. PMID: 36290819. Review.

Lim-Fat MJ, Macdonald M, Lapointe S, Climans SA, Cacciotti C, Chahal M, Perreault S, Tsang DS, Gao A, Yip S, Keith J, Bennett J, Ramaswamy V, Detsky J, Tabori U, Das S, Hawkins C.
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline.
Front Oncol. 2022 Sep 23, 2022;12:960509. doi: 10.3389/fonc.2022.960509. PMID: 36249063. Guidelines.

Rossi J, Cavallieri F, Biagini G, Rizzi R, Russo M, Cozzi S, Giaccherini L, Pisanello A, Valzania F.
Epileptogenesis and Tumorigenesis in Glioblastoma: Which Relationship?
Medicina (Kaunas). 2022 Sep 26, 2022;58(10):1349. doi: 10.3390/medicina58101349. PMID: 36295510. Review.

Song S, Wu H, Wang F, Jiao J, Xu L, Wang H, Tong X, Yan H.
Global research trends and hotspots on glioma stem cells.
Front Oncol. 2022 Sep 29, 2022;12:926025. doi: 10.3389/fonc.2022.926025. PMID: 36248966. Bibliometric analysis.

Zhou Y, Fang C, Xu H, Yuan L, Liu Y, Wang X, Zhang A, Shao A, Zhou D.
Ferroptosis in glioma treatment: Current situation, prospects and drug applications.
Front Oncol. 2022 Sep 29, 2022;12:989896. doi: 10.3389/fonc.2022.989896. PMID: 36249003. Review.

Buccarelli M, Castellani G, Ricci-Vitiani L.
Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance.
J Pers Med. 2022 Oct 1, 2022;12(10):1625. doi: 10.3390/jpm12101625. PMID: 36294763. Review.

Daneshimehr F, Barabadi Z, Abdolahi S, Soleimani M, Verdi J, Ebrahimi-Barough S, Ai J.
Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches.
Cell J. 2022 Oct 1, 2022;24(10):555-568. doi: 10.22074/cellj.2022.8154. PMID: 36259473. Review.

Guha A, Goda JS, Dasgupta A, Mahajan A, Halder S, Gawde J, Talole S.
Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis.
Front Oncol. 2022 Oct 3, 2022;12:884173. doi: 10.3389/fonc.2022.884173. PMID: 36263203. Review, Meta-analysis.

Choi SI, Yin J.
Prospective approaches to enhancing CAR T cell therapy for glioblastoma.
Front Immunol. 2022 Oct 6, 2022;13:1008751. doi: 10.3389/fimmu.2022.1008751. PMID: 36275671. Review.

Sánchez-Villalobos JM, Aledo-Serrano Á, Villegas-Martínez I, Shaikh MF, Alcaraz M.
Epilepsy treatment in neuro-oncology: A rationale for drug choice in common clinical scenarios.
Front Pharmacol. 2022 Oct 6, 2022;13:991244. doi: 10.3389/fphar.2022.991244. PMID: 36278161. Review.

Bartusik-Aebisher D, Żołyniak A, Barnaś E, Machorowska-Pieniążek A, Oleś P, Kawczyk-Krupka A, Aebisher D.
The Use of Photodynamic Therapy in the Treatment of Brain Tumors-A Review of the Literature.
Molecules. 2022 Oct 13, 2022;27(20):6847. doi: 10.3390/molecules27206847. PMID: 36296440. Review.

van Bree NFHN, Wilhelm M.
The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential.
Cancers (Basel). 2022 Oct 13, 2022;14(20):5009. doi: 10.3390/cancers14205009. PMID: 36291792. Review.

Gaca-Tabaszewska M, Bogusiewicz J, Bojko B.
Metabolomic and Lipidomic Profiling of Gliomas-A New Direction in Personalized Therapies.
Cancers (Basel). 2022 Oct 14, 2022;14(20):5041. doi: 10.3390/cancers14205041. PMID: 36291824. Review.

Gueble SE, Vasquez JC, Bindra RS.
The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.
Curr Treat Options Oncol. 2022 Oct 15, 2022;23(11):1566-1589. doi: 10.1007/s11864-022-01024-5. PMID: 36242713. Review˰

Knisely JPS, Fine HA.
Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not.
J Clin Oncol. 2022 Oct 19, 2022:JCO2201785. doi: 10.1200/JCO.22.01785. PMID: 36260825. Case report, Review.

Mackenzie P, Vajdic C, Delaney G, Comans T, Morris L, Agar M, Gabriel G, Barton M.
Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
J Geriatr Oncol. 2022 Oct 19, 2022:S1879-4068(22)00236-3. doi: 10.1016/j.jgo.2022.10.002. PMID: 36272958. Review˰

Marabitti V, Giansanti M, De Mitri F, Gatto F, Mastronuzzi A, Nazio F.
Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma.
Front Cell Dev Biol. 2022 Oct 19, 2022;10:1007641. doi: 10.3389/fcell.2022.1007641. PMID: 36340043. Review.

Andersen BM, Reardon DA.
Immunotherapy approaches for adult glioma: knowledge gained from recent clinical trials.
Curr Opin Neurol. 2022 Oct 21, 2022;35(6):803-813. doi: 10.1097/WCO.0000000000001118. PMID: 36367046. Review˰


Jovanovich N, Habib A, Head J, Anthony A, Edwards L, Zinn PO.
Opinion: Bridging gaps and doubts in glioblastoma cell-of-origin.
Front Oncol. 2022 Oct 21, 2022;12:1002933. doi: 10.3389/fonc.2022.1002933. PMID: 36338762. Opinion.

Mallick S, Benson R, Venkatesulu B, Melgandi W, Rath GK.
Systematic Review and Individual Patient Data Analysis of Uncommon Variants of Glioblastoma: An Analysis of 196 Cases.
Neurol India. 2022 Oct 21, 2022;70(5):2086-2092. doi: 10.4103/0028-3886.359222. PMID: 36352613. Review.

Niemi JVL, Sokolov AV, Schiöth HB.
Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments.
Cancers (Basel). 2022 Oct 21, 2022;14(20):5163. doi: 10.3390/cancers14205163. PMID: 36291947. Review.

Sachdeva P, Ghosh S, Ghosh S, Han S, Banerjee J, Bhaskar R, Sinha JK.
Childhood Obesity: A Potential Key Factor in the Development of Glioblastoma Multiforme.
Life (Basel). 2022 Oct 21, 2022;12(10):1673. doi: 10.3390/life12101673. PMID: 36295107. Review.

Yuile A, Satgunaseelan L, Wei J, Kastelan M, Back MF, Lee M, Wei H, Buckland ME, Lee A, Wheeler HR.
Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma-A Case Report and Systematic Review.
Curr Issues Mol Biol. 2022 Oct 21, 2022;44(10):5117-5125. doi: 10.3390/cimb44100348. PMID: 36286062. Case report, Review.

Malhotra AK, Karthikeyan V, Zabih V, Landry A, Bennett J, Bartels U, Nathan PC, Tabori U, Hawkins C, Das S, Gupta S.
Adolescent and young adult glioma: systematic review of demographic, disease, and treatment influences on survival.
Neurooncol Adv. 2022 Oct 22, 2022;4(1):vdac168
. doi: 10.1093/noajnl/vdac168. PMID: 36479061. Review.

Fioni F, Song JC, Ma ZL, Ghalwash AA.
Differentiation of high grade glioma and solitary brain metastases by measuring relative cerebral blood volume and fractional anisotropy: A systematic review and Meta-Analysis of MRI diagnostic test accuracy studies.
Br J Radiol. 2022 Oct 24, 2022:20220052. doi: 10.1259/bjr.20220052. PMID: 36278795. Review, Meta-analysis.

Lehrer EJ, Kowalchuk RO, Ruiz-Garcia H, Merrell KW, Brown PD, Palmer JD, Burri SH, Sheehan JP, Quninoes-Hinojosa A, Trifiletti DM.
Preoperative stereotactic radiosurgery in the management of brain metastases and gliomas.
Front Surg. 2022 Oct 24, 2022;9:972727. doi: 10.3389/fsurg.2022.972727. PMID: 36353610. Review.

Ling SP, Ming LC, Dhaliwal JS, Gupta M, Ardianto C, Goh KW, Hussain Z, Shafqat N.
Role of Immunotherapy in the Treatment of Cancer: A Systematic Review.
Cancers (Basel). 2022 Oct 24, 2022;14(21):5205. doi: 10.3390/cancers14215205. PMID: 36358624. Review.

Li H, Duan Y, Liu N, Dong J, Liang Y, Ju R.
Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis.
Int J Clin Pract. 2022 Oct 25, 2022;2022:1629570. doi: 10.1155/2022/1629570. PMID: 36380750. Meta-analysis.

Bunse L, Bunse T, Krämer C, Chih YC, Platten M.
Clinical and Translational Advances in Glioma Immunotherapy.
Neurotherapeutics. 2022 Oct 27. doi: 10.1007/s13311-022-01313-9. PMID: 36303101. Review.

Giambra M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera V, Basso G, Moresco RM, Giussani C, Bentivegna A.
The peritumoral brain zone in glioblastoma: where we are and where we are going.
J Neurosci Res. 2022 Oct 27. doi: 10.1002/jnr.25134. PMID: 36300592. Review.

Lim YJ.
Medical Treatment of Pediatric Low-Grade Glioma.
Brain Tumor Res Treat. 2022 Oct 27, 2022;10(4):221-225. doi: 10.14791/btrt.2022.0039. PMID: 36347636. Review.

Schirrmacher V, van Gool S, Stuecker W.
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.
Int J Mol Sci. 2022 Oct 27, 2022;23(21):13050. doi: 10.3390/ijms232113050. PMID: 36361831. Review.

Hosseinalizadeh H, Habibi Roudkenar M, Mohammadi Roushandeh A, Kuwahara Y, Tomita K, Sato T.
Natural killer cell immunotherapy in glioblastoma.
Discov Oncol. 2022 Oct 28, 2022;13(1):113. doi: 10.1007/s12672-022-00567-1. PMID: 36305981. Review.

Kutty S.
A summary of common grading systems used in neurosurgical practice.
Surg Neurol Int. 2022 Oct 28, 2022;13:497
. doi: 10.25259/SNI_731_2022. PMID: 36447867. Review.

Li J, Feng L, Lu Y.
Glioblastoma multiforme: Diagnosis, treatment, and invasion.
J Biomed Res. 2022 Oct 28, 2022:1-11. doi: 10.7555/JBR.36.20220156. PMID: 36403983. Review.

Luo Y, Tian G, Fang X, Bai S, Yuan G, Pan Y.
Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities.
Antioxidants (Basel). 2022 Oct 28, 2022;11(11):2123. doi: 10.3390/antiox11112123. PMID: 36358495. Review.

Qi X, Jha SK, Jha NK, Dewanjee S, Dey A, Deka R, Pritam P, Ramgopal K, Liu W, Hou K.
Antioxidants in brain tumors: current therapeutic significance and future prospects.
Mol Cancer. 2022 Oct 28, 2022;21(1):204. doi: 10.1186/s12943-022-01668-9. PMID: 36307808. Review.

Catalano M, Serpe C, Limatola C.
Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma.
Int J Mol Sci. 2022 Oct 29, 2022;23(21):13165. doi: 10.3390/ijms232113165. PMID: 36361947. Review.

Foo CY, Munir N, Kumaria A, Akhtar Q, Bullock CJ, Narayanan A, Fu RZ.
Medical Device Advances in the Treatment of Glioblastoma.
Cancers (Basel). 2022 Oct 29, 2022;14(21):5341. doi: 10.3390/cancers14215341. PMID: 36358762. Review.

Goldman M, Lucke-Wold B, Martinez-Sosa M, Katz J, Mehkri Y, Valisno J, Quintin S.
Steroid utility, immunotherapy, and brain tumor management: an update on conflicting therapies.
Explor Target Antitumor Ther. 2022 Oct 31, 2022;3(5):659-675. doi: 10.37349/etat.2022.00106. PMID: 36338521. Review.

Szklener K, Mazurek M, Wieteska M, Wacławska M, Bilski M, Mańdziuk S.
New Directions in the Therapy of Glioblastoma.
Cancers (Basel). 2022 Oct 31, 2022;14(21):5377. doi: 10.3390/cancers14215377. PMID: 36358795. Review.